Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.

Authors

Amber N. Edinoff, Louisiana State University Health Science Center
Catherine A. Nix, Louisiana State University
Amira S. Odisho, Louisiana State University
Caroline P. Babin
Alyssa G. Derouen
Salim C. Lutfallah
Elyse M. Cornett, Louisiana State University
Kevin S. Murnane, Louisiana State University
Adam M. Kaye, University of the PacificFollow
Alan David Kaye, Louisiana State University Health Science Center

ORCiD

Adam M. Kaye: 0000-0002-7224-3322

Document Type

Article

Publication Title

Neurology international

ISSN

2035-8385

Volume

14

Issue

3

DOI

10.3390/neurolint14030053

First Page

648

Last Page

663

Publication Date

8-22-2022

Abstract

As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-4

Recommended Citation

Edinoff, A. N., Nix, C. A., Odisho, A. S., Babin, C. P., Derouen, A. G., Lutfallah, S. C., Cornett, E. M., Murnane, K. S., Kaye, A. M., & Kaye, A. D. (2022). Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.. Neurology international, 14(3), 648–663. DOI: 10.3390/neurolint14030053
https://scholarlycommons.pacific.edu/phs-facarticles/661

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.